Conscientia Health announces its position as a nationwide hybrid care platform integrating AI to enhance mental health and primary care outcomes.
Browsing Category
Healthcare Operations
44 posts
Physician’s Choice 60 Billion Probiotic® Advanced To Launch In 625 Costco Warehouses Nationwide
Physician’s Choice 60 Billion Probiotic® Advanced will be available in 625 Costco stores nationwide, expanding its retail distribution.
Scientific Paper Detailing Preclinical Studies Of Narmafotinib In Pancreatic Cancer Now Online
A scientific paper details preclinical research on Narmafotinib’s effects on pancreatic cancer, marking a step toward potential new treatments.
Practice At The Speed Of Innovation™ A New Podcast And Video Series Exploring The AI Enabled Future Of Community Oncology Presented By Oncologic.ai
Oncologic.ai announces a new podcast and video series exploring AI’s role in community oncology, aiming to accelerate practice innovation.
Ascentage Pharma Chairman And CEO Dr. Dajun Yang Named To The Medicine Maker Power List 2026
Ascentage Pharma’s Chairman and CEO Dr. Dajun Yang has been recognized on The Medicine Maker Power List 2026, highlighting his influence in pharmaceutical innovation.
The Promise Of CRISPR: Safer, More Effective Cancer Cell Elimination For Consumers
New research indicates CRISPR technology can selectively destroy cancer cells, including hard-to-treat types, offering potential for safer therapies.
Supernus Pharmaceuticals To Announce Second Quarter 2026 Financial Results And Host Conference Call On August 4, 2026
Supernus Pharmaceuticals will release its second quarter 2026 financial results and host a conference call on August 4, 2026, according to a recent announcement.
TransMedics To Report Second Quarter 2026 Financial Results On August 4, 2026
TransMedics will report its second quarter 2026 financial results on August 4, 2026, providing updates on its financial performance and business outlook.
The Role Of Daily Postpartum Checks In Maternal Healing
Early testing of daily postpartum check-ins for first-time mothers aims to improve recovery monitoring and reduce health risks after discharge.
4DMT Announces Positive 2-Year Data From PRISM Phase 2B Clinical Trial In A Broad Wet AMD Population
4DMT announces favorable 2-year data from its PRISM Phase 2b trial in wet AMD, showing promising efficacy and safety. Details remain under review.